ClinConnect ClinConnect Logo
Search / Trial NCT06809582

Impact of Surgical Position on Stone-Free Rates in Retrograde Intrarenal Surgery

Launched by ONDOKUZ MAYIS UNIVERSITY · Jan 30, 2025

Trial Information

Current as of May 18, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring how the position of patients during a specific kidney stone surgery called retrograde intrarenal surgery (RIRS) affects the chances of being stone-free afterward. The researchers want to find out if a modified position, where the patient is tilted at a 30-degree angle with the surgical side elevated, leads to better outcomes compared to the standard position. They will also look at whether there are any differences in complications that might arise from using these two positions.

To participate, you must be an adult with one or more kidney stones that are not larger than 2 centimeters. You'll need to give your consent to join the study and undergo the surgery. Participants will be randomly assigned to either the standard or modified position, and follow-up imaging will be done after the surgery to check if the stones have been successfully cleared. This study aims to enhance treatment techniques for kidney stones and improve patient results.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Presence of single or multiple kidney stones, with the largest stone ≤2 cm
  • Age ≥18 years
  • Provided written informed consent to participate in the study
  • Indicated for retrograde intrarenal surgery (RIRS) as a treatment approach
  • Exclusion Criteria:
  • Severe cardiovascular disease (e.g., heart failure)
  • Congenital kidney anomalies (e.g., horseshoe kidney, ectopic kidney)
  • Concurrent ureteral stones
  • Pregnancy or planning pregnancy
  • History of previous kidney surgery on the same side
  • Active urinary tract infection (UTI)
  • Coagulopathy or use of anticoagulant therapy that cannot be stopped before surgery

About Ondokuz Mayıs University

Ondokuz Mayıs University is a prestigious academic institution located in Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its cutting-edge facilities and a multidisciplinary team of experts to conduct innovative studies that aim to enhance patient care and contribute to scientific knowledge. With a focus on ethical standards and rigorous methodologies, Ondokuz Mayıs University is dedicated to fostering collaborations that drive breakthroughs in healthcare, ultimately improving treatment outcomes and patient well-being.

Locations

Samsun, , Turkey

Patients applied

0 patients applied

Trial Officials

Murat Gulsen

Principal Investigator

Ondokuz Mayıs University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported